GBA1 and Cognitive impairment: Thus, measurements of L1EV α-synuclein in combination with specific prodromal markers, such as olfactory or cognitive deficit, possible or definite RBD or GBA1 gene status could be harnessed to aid the substratification of those at-risk individuals with the highest probability of developing PD and related Lewy body diseases.